Press Releases

All Releases
Apr 10, 2018
AngioDynamics to Present at Two Investor Conferences in May
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics , Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will present at the following two investor conferences in May:
Mar 29, 2018
AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
Fiscal 2018 Third Quarter Highlights Net sales of $83.9 million , a decrease of 2.0% year over year Gross margin expanded 300 basis points year over year to 54.2% GAAP EPS of $0.37 ; Adjusted EPS of $0.25 per share Announced the launch of a wireless ultrasound device FDA granted Breakthrough
Feb 15, 2018
AngioDynamics to Present at the Barclays Global Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics , Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and Michael C.
Jan 04, 2018
AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
Fiscal 2018 Second Quarter Highlights Net sales of $86.7 million , a decrease of 2.6% year over year U.S. GAAP EPS of $0.01 ; Adjusted EPS of $0.16 per share Operating cash flow of $10.2 million ; free cash flow of $9.4 million LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics , Inc. (NASDAQ:ANGO), a
Dec 19, 2017
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 19, 2017-- AngioDynamics , Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Jim Clemmer , President and Chief Executive Officer,
Sep 28, 2017
AngioDynamics Reports Fiscal 2018 First Quarter Results
Q1 net sales of $85.4 million , down 3% year-over-year              Q1 GAAP earnings per share of $0.00 ; adjusted EPS of $0.12 Q1 operating cash generation of $3.0 million ; free cash flow generation of $2.5 million Company reaffirms fiscal 2018 guidance ALBANY, N.Y. , Sept.
Sep 14, 2017
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
ALBANY, N.Y. , Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2018 first
Displaying 21 - 40 of 637